Raphetamine en es it fr

Raphetamine Brand names, Raphetamine Analogs

Raphetamine Brand Names Mixture

  • Adderall (amphetamine + dextroamphetamine)
  • Adderall XR 10mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
  • Adderall XR 15mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
  • Adderall XR 20mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
  • Adderall XR 25mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
  • Adderall XR 30mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
  • Adderall XR 5mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)

Raphetamine Chemical_Formula

C9H13N

Raphetamine RX_link

http://www.rxlist.com/cgi/generic3/adderallxr.htm

Raphetamine fda sheet

Raphetamine msds (material safety sheet)

Raphetamine Synthesis Reference

U. S. Pat. 1,879,003, (1932)

Raphetamine Molecular Weight

135.206 g/mol

Raphetamine Melting Point

Volatizes slowly at room temperature

Raphetamine H2O Solubility

Slightly

Raphetamine State

Solid

Raphetamine LogP

1.799

Raphetamine Dosage Forms

Capsules

Raphetamine Indication

For treatment of Attention Deficit Disorder with Hyperactivity (ADDH) and narcolepsy in children.

Raphetamine Pharmacology

Amphetamine and dextroamphetamine, non-catechloamine sypathomimetic agents, are used in combination to treat attention-deficit hyperactivity disorder (ADHD) or narcolepsy. Adderall consists of equivalent amounts of amphetamine aspartate, amphetamine sulfate, dextroamphetamine saccharate, and dextroamphetamine sulfate.

Raphetamine Absorption

It forms easily absorbed molecules that are highly lipid soluble

Raphetamine side effects and Toxicity

LD50=180 mg/kg(s.c in rat). The most common presenting symptoms seen are agitation, hallucinations, suicidal behaviour, and chest pain.

Raphetamine Patient Information

Amphetamines may impair the ability of the patient to engage in potentially hazardous activities such as operating machinery or vehicles; the patient should therefore be cautioned accordingly.

Raphetamine Organisms Affected

Humans and other mammals